Formula: | C17H19F3N4O3 |
Molecular Weight: | 384.36 |
Rotatable Bond Donors: | 5 |
clogP: | 2.41 |
Topological Polar Surface Area: | 78.27 |
Lipinski's RO5: | MW: 384.36 HBA: 7 HBD: 1 RB: 5 LogP: 2.41 |
Rule of Three: | MW: 384.36 HBA: 7 HBD: 1 RB: 5 LogP: 2.41 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC626226632 | 1.0 | ZINC626226632 RDKit 3D 27 29 0 0 0 0 0 0 0 0999 V2000 -0.2022 0.3887 3.3479 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0822 0.6446 1.8582 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3766 2.0762 1.6736 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9398 -0.3038 1.2450 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2218 -0.1642 1.8525 O 0 0 0 0 0 0 0 0 0 0 0 0 3.1791 -0.0454 0.8668 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4977 -0.0380 1.2909 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4825 0.1034 0.3216 C 0 0 0 0 0 0 0 0 0 0 0 0 5.1303 0.2256 -1.0186 C 0 0 0 0 0 0 0 0 0 0 0 0 6.1402 0.4174 -2.0900 C 0 0 0 0 0 0 0 0 0 0 0 0 6.3493 1.7313 -2.3772 F 0 0 0 0 0 0 0 0 0 0 0 0 5.7902 -0.1711 -3.2669 F 0 0 0 0 0 0 0 0 0 0 0 0 7.3624 -0.0936 -1.7739 F 0 0 0 0 0 0 0 0 0 0 0 0 3.7864 0.2267 -1.3339 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7985 0.0936 -0.4230 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3741 0.4998 1.2202 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.0669 -0.6909 1.1505 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6437 -1.7508 1.6085 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.3560 -0.5733 0.4744 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2451 -1.6126 0.2558 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.2879 -1.0389 -0.3994 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.0363 0.2914 -0.5730 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8742 0.6126 -0.0440 N 0 0 0 0 0 0 0 0 0 0 0 0 -6.0359 1.1705 -1.2412 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.8691 0.3613 -2.0858 O 0 0 0 0 0 0 0 0 0 0 0 0 -7.5018 -0.6577 -1.3088 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.4794 -1.7028 -0.8797 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 2 4 1 0 4 5 1 0 5 6 1 0 6 7 2 0 7 8 1 0 8 9 2 0 9 10 1 0 10 11 1 0 10 12 1 0 10 13 1 0 9 14 1 0 14 15 2 0 2 16 1 0 16 17 1 0 17 18 2 0 17 19 1 0 19 20 2 0 20 21 1 0 21 22 1 0 22 23 2 0 22 24 1 0 24 25 1 0 25 26 1 0 26 27 1 0 15 6 1 0 23 19 1 0 27 21 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |